Israel Englander’s Medifast MED Stock Holding History

Israel Englander’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,000	Closed	-$705K	–	6193
2024 Q4	$705K	Buy	+40,000	New	+$742K	﹤0.01%	4474
2024 Q2	–	Sell	-40,000	Closed	-$1.53M	–	6283
2024 Q1	$1.53M	Buy	+40,000	New	+$1.94M	﹤0.01%	3957
2023 Q3	–	Sell	-20,000	Closed	-$1.84M	–	6375
2023 Q2	$1.84M	Buy	20,000 +10,000	+100%	+$890K	﹤0.01%	3557
2023 Q1	$1.04M	Buy	10,000 +5,000	+100%	+$554K	﹤0.01%	4062
2022 Q4	$577K	Buy	5,000 +3,000	+150%	+$349K	﹤0.01%	4631
2022 Q3	$217K	Buy	+2,000	New	+$287K	﹤0.01%	5606
2022 Q1	–	Sell	-3,000	Closed	-$628K	–	7245
2021 Q4	$628K	Buy	+3,000	New	+$620K	﹤0.01%	4844
2019 Q4	–	Sell	-5,000	Closed	-$518K	–	4476
2019 Q3	$518K	Buy	5,000 +3,000	+150%	+$322K	﹤0.01%	3235
2019 Q2	$257K	Buy	+2,000	New	+$278K	﹤0.01%	3618

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Israel Englander's MED Position: Q2 2026 in Review

Israel Englander opened a new position in Medifast (MED) in Q2 2026: 47,906 shares worth $508K. The stake represents ﹤0.01% of the portfolio and ranks #4762 among its holdings. This is a return to the name: Israel Englander previously reported a position in MED as recently as Q2 2025.

Israel Englander first reported a position in MED in Q2 2013 and has held it in 48 quarters since. The position peaked at $41.3M in Q1 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Israel Englander held 47,906 shares of Medifast worth $508K as of Q2 2026.
Medifast was a new Israel Englander position in Q2 2026.
Medifast made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4762 holding.
Israel Englander first reported a position in Medifast in Q2 2013 and has held it in 48 quarters since.
Israel Englander's Medifast position peaked at $41.3M in Q1 2023.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.